Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
NIH OD · N01
Biological Testing Facility: In Vivo Efficacy, Validation and Preclinical Development for Fertility Regulation, Multipurpose Prevention Technology and Reproductive Health Related Products
Sri International· Menlo Park, United States· US$1,719,885 awarded in fiscal year 2026· until Sept 2028
NIH NINDS · RF1
Neuroendocrine mechanisms of female chronic overlapping pain conditions (COPC)
University of Arizona· Tucson, United States· US$3,462,365 awarded in fiscal year 2026· until Aug 2030
NIH NICHD · R01
Decoding Dysmenorrhea: Longitudinal Modeling of Pelvic Pain Phenotypes in Adolescents and Young Adults
Mclean Hospital· Belmont, United States· US$695,377 awarded in fiscal year 2026· until May 2031
NIH NIAID · R01
Mycoplasma genitalium in Women: Natural History, Clinical Sequelae, and Host-Microbiome-Mediated Clearance
University of Maryland Baltimore· Baltimore, United States· US$804,984 awarded in fiscal year 2026· until Aug 2031
NIH NEI · R01
Beyond the Eye: Nociplastic Pain as a Predictor of Treatment Response in Chronic Ocular Surface Pain
University of Michigan at Ann Arbor· Ann Arbor, United States· US$690,677 awarded in fiscal year 2026· until May 2031
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF
Tracking the Intestinal Permeation and Circulation Effects of Environmental MicroPlastics (TRACE-MP)
Queen Mary University of London· London, United Kingdom· EU contribution €292,073· until Jan 2029· 2 countries
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC-POC
Uro-Lieve: Slow-Release Capsaicin Hydrogel for Disease-Modifying Therapy of Painful Bladder Syndrome
University of Galway· Galway, Ireland· EU contribution €150,000· until Nov 2027
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC-POC
Simultaneous Yield of Non-invasive uterine Contractions via Wearable Observation and Real-time Monitoring A wearable platform for dynamic uterine motion capture. (SyncWorm)
Gottfried Wilhelm Leibniz Universitaet Hannover· Hannover, Germany· EU contribution €150,000· until Nov 2027
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE
Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility (TULIP)
Karolinska Institutet· Stockholm, Sweden· EU contribution €1,803,600· until Dec 2029· 6 countries
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Investigating how somatic mutation induced changes in the eutopic endometrial microenvironment cause endometriosis (MERMAID)
Stichting Radboud Universitair Medisch Centrum· Nijmegen, Netherlands· EU contribution €232,916· until Dec 2027
10 of 215 running projects, newest first. Listed amounts together: US$125.5m + €27.6m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.